Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa(1)-Arg-(pI)DPhe-Xaa(4)-NH2

作者：Doering Skye R; Freeman Katie T; Schnell Sathya M; Haslach Erica M; Dirain Marvin; Debevec Ginamarie; Geer Phaedra; Santos Radleigh G; Giulianotti Marc A; Pinilla Clemencia; Appel Jon R; Speth Robert C; Houghten Richard A; Haskell Luevano Carrie

来源：Journal of Medicinal Chemistry, 2017, 60(10): 4342-4357.

DOI：10.1021/acs.jmedchem.7b00301

The centrally expressed melanocortin-3 and -4 receptors (MC3R/MC4R) have been studied as possible targets for weight management therapies, with a preponderance of studies focusing on the MC4R. Herein, a novel tetrapeptide scaffold [Ac-Xaa(1)-Arg-(pI)DPhe-Xaa(4)-NH2] is reported. The scaffold was derived from results obtained from a MC3R mixture-based positional scanning campaign. From these results, a set of 48 tetrapeptides were designed and pharmacologically characterized at the mouse melanocortin-1, -3, -4, and -5 receptors. This resulted in the serendipitous discovery of nine compounds that were MC3R agonists (EC50 < 1000 nM) and MC4R antagonists (5.7 < pA(2) < 7.8). The three most potent MC3R agonists, 18 [Ac-Arg-Arg-(pI)DPhe-Tic-NH2], 1 [Ac-His-Arg-(pI)DPhe-Tic-NH2], and 41 [Ac-Arg-Arg-(pI)DPhe-DNal(2')-NH2] were more potent (EC50 < 73 nM) than the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2. This template contains a sequentially reversed "Arg-(pI)DPhe" motif with respect to the. classical "Phe-Arg" melanocortin signaling motif; which results in pharmacology that is first-in-class for the central melanocortin receptors.

• 出版日期2017-5-25
• 单位东南大学